ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
SCI一区
EI同步收录
月刊
高认可度
更新时间: 浏览量:
期刊基础介绍
ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application.
ASSAY and Drug Development Technologies coverage includes:
-Assay design, target development, and high-throughput technologies-
Hit to Lead optimization and medicinal chemistry through preclinical candidate selection-
Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis-
Approaches to assays configured for gene families, inherited, and infectious diseases-
Assays and strategies for adapting model organisms to drug discovery-
The use of stem cells as models of disease-
Translation of phenotypic outputs to target identification-
Exploration and mechanistic studies of the technical basis for assay and screening artifacts
ASSAY and Drug Development Technologies coverage includes:
-Assay design, target development, and high-throughput technologies-
Hit to Lead optimization and medicinal chemistry through preclinical candidate selection-
Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis-
Approaches to assays configured for gene families, inherited, and infectious diseases-
Assays and strategies for adapting model organisms to drug discovery-
The use of stem cells as models of disease-
Translation of phenotypic outputs to target identification-
Exploration and mechanistic studies of the technical basis for assay and screening artifacts
期刊核心参数
通讯方式
MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801
涉及的研究方向
医学-生化研究方法
出版国家或地区
UNITED STATES
出版语言
English
年文章数
29
PubMed Central (PMC)链接
平均录用比例
较易
CITESCORE
| CiteScore | SJR | SNIP | CiteScore排名 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.30 | 0.308 | 0.544 |
|
WOS期刊JCR分区
WOS分区等级:3区| 按JIF指标学科分区 | 收录子集 | JIF分区 | JIF排名 | JIF百分位 |
| 学科:BIOCHEMICAL RESEARCH METHODS | SCIE | Q4 | 66/86 |
|
| 学科:PHARMACOLOGY & PHARMACY | SCIE | Q3 | 256/352 |
|
| 按JCI指标学科分区 | 收录子集 | JCI分区 | JCI排名 | JCI百分位 |
| 学科:BIOCHEMICAL RESEARCH METHODS | SCIE | Q4 | 72/86 |
|
| 学科:PHARMACOLOGY & PHARMACY | SCIE | Q4 | 266/353 |
|
期刊分区表预警名单
2025年03月发布的2025版:不在预警名单中2024年02月发布的2024版:不在预警名单中
2023年01月发布的2023版:不在预警名单中
2021年12月发布的2021版:不在预警名单中
2020年12月发布的2020版:不在预警名单中
中科院2025年3月升级版
点击查看中国科学院期刊分区趋势图| 大类学科 | 小类学科 | Top期刊 | 综述期刊 | ||||
|---|---|---|---|---|---|---|---|
| 医学 4区 |
| 否 | 否 |
中科院2023年12月旧的升级版
| 大类学科 | 小类学科 | Top期刊 | 综述期刊 | ||||
|---|---|---|---|---|---|---|---|
| 医学 4区 |
| 否 | 否 |